---
title: Transparency, trustworthiness and usefulness in pre-eclampsia randomised controlled
  trials in the last three decades
date: '2024-12-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39721398/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241226170935&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The reporting of non-significant p-values and effect sizes
  increased after mandatory trial registration in 2010, along with the transparency
  and trustworthiness of most trials. RCTs need to be more transparent, trustworthy,
  and useful to increase the value of ...'
disable_comments: true
---
CONCLUSION: The reporting of non-significant p-values and effect sizes increased after mandatory trial registration in 2010, along with the transparency and trustworthiness of most trials. RCTs need to be more transparent, trustworthy, and useful to increase the value of ...